ATZORI, MARIA GRAZIA

ATZORI, MARIA GRAZIA  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.016 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
16-lug-2022 A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose Sbardella, D; Tundo, Gr; Mecchia, A; Palumbo, C; Atzori, Mg; Levati, L; Boccaccini, A; Caccuri, Am; Cascio, P; Lacal, Pm; Graziani, G; Varano, M; Coletta, M; Parravano, M Articolo su rivista
1-gen-2016 Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P Intervento a convegno
1-gen-2016 Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P Articolo su rivista
1-gen-2016 Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth Ceci, C; Tentori, L; Atzori, Mg; Lacal, P; Bonanno, E; Scimeca, M; Cicconi, R; Mattei, M; De Martino, M; Vespasiani, G; Miano, R; Graziani, G Articolo su rivista
1-gen-2024 Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research Ceci, C; Garcia-Chico, C; Atzori, Mg; Lacal, Pm; Lista, S; Santos-Lozano, A; Graziani, G; Pinto-Fraga, J Articolo su rivista
1-gen-2024 Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential Ceci, C; Ruffini, F; Falconi, M; Grazia Atzori, M; Falzon, A; Lozzi, F; Iacovelli, F; D'Atri, S; Graziani, G; Miguel Lacal, P Articolo su rivista
1-gen-2017 Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1. Ruffini, F; Levati, L; Graziani, G; Caporali, S; Atzori, M; D'Atri, S; Lacal, P Articolo su rivista
1-gen-2018 Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells. Lacal, P; Atzori, M; Ruffini, F; Tentori, L; Graziani, G Articolo su rivista
1-gen-2020 Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib Atzori, Mg; Ceci, C; Ruffini, F; Trapani, M; Barbaccia, Ml; Tentori, L; D'Atri, S; Lacal, Pm; Graziani, G Articolo su rivista
29-apr-2023 Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors Ruffini, F; Ceci, C; Atzori, Mg; Caporali, S; Levati, L; Bonmassar, L; Cappellini, Gca; D'Atri, S; Graziani, G; Lacal, Pm Articolo su rivista
14-nov-2022 The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor Atzori, Mg; Ceci, C; Ruffini, F; Scimeca, M; Cicconi, R; Mattei, M; Lacal, Pm; Graziani, G Articolo su rivista
1-gen-2018 The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G Articolo su rivista